Lessons From A Private Funding Round: Science, Relationships, And Experience
LifeSciVC
APRIL 2, 2024
We are confident that there is room for improvement over existing cystic fibrosis (CF) therapies because we have not yet achieved fully normalized function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein. We experienced strong enthusiasm for small molecule research in the investor community.
Let's personalize your content